Celldex Therapeutics Stock Target Price and Analyst Consensus
| CLDX Stock | USD 23.35 0.13 0.56% |
The current analyst and expert consensus on Celldex Therapeutics is Strong Buy, with 10 strong buy opinions. The current projected Celldex Therapeutics target price consensus is 57.25 with 14 analyst opinions. Check out Macroaxis Advice on Celldex Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Celldex Stock please use our How to Invest in Celldex Therapeutics guide.The most common way Celldex Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Celldex Therapeutics executives and customers to further validate their buy or sell advice. Celldex Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Celldex Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.5964.
Lowest Forecast 52.1 | Highest Forecast 63.55 | Target Price 57.25 |
It's important to approach Celldex Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Celldex Therapeutics Target Price Consensus
Celldex target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Celldex Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Strong Buy |
Most Celldex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Celldex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Celldex Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCelldex Therapeutics Target Price Projection
Celldex Therapeutics' current and average target prices are 23.35 and 57.25, respectively. The current price of Celldex Therapeutics is the price at which Celldex Therapeutics is currently trading. On the other hand, Celldex Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Celldex Therapeutics Market Quote on 28th of July 2025
Target Price
Analyst Consensus On Celldex Therapeutics Target Price
Celldex Therapeutics Analyst Ratings
Celldex Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Celldex Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Celldex Therapeutics' financials, market performance, and future outlook by experienced professionals. Celldex Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Celldex Therapeutics price targets
Celldex Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Celldex Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Celldex Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Celldex Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Celldex Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Celldex Therapeutics is a key component of Celldex Therapeutics valuation and have some predictive power on the future returns of a Celldex Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celldex Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Target Risk ETFs Invested over 200 shares | |
| Broad Equity ETFs Invested over 100 shares | |
| Strategy ETFs Invested over 100 shares | |
 | Macroaxis Index Invested over 500 shares | |
| Investment Grade ETFs Invested over 400 shares | |
 | Dividend Beast Invested over 100 shares | |
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.